Other Names for this Disease
- Lymphoma, follicular
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- ClinicalTrials.gov lists trials that are studying or have studied Follicular lymphoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
The FDA has approved this product to be used in this manner.
|Indicated for the treatment of patients with follicular lymphoma (FL) who relapsed after, or are refractory to, a rituximab containing regimen.|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information